Current Issue
Volume: 122
Number: 4
Index: July 2010
Clinical Focus: Neurological disorders and depression
Call For Papers
September 2010
Clinical Focus: ADHD, Allergies, Immunization, and Diabetes
  • Attention-deficit/hyperactivity disorder:
    • ADHD
      • Treating children, adolescents, and adults
      • Pharmacotherapy options
      • Switching medication dosages
      • Treating ADHD in patients with concomitant disorders
      • Clinical trial developments
    • Oppositional defiant disorder
  • Immunization and pediatrics:
    • Vaccinations for infants, children, and adults:
      • HPV
      • Meningococcal
      • Influenza
    • Physical examinations for back-to-school
    • Allergy medications
    • Treating asthma in children and adolescents
  • Diabetes:
    • Juvenile diabetes
    • New drug developments for type 1 and type 2 diabetes
    • Pen devices
    • Managing diabetes in patients with concomitant disorders:
      • Obesity
      • Metabolic syndrome
      • Cardiovascular disease
      • Chronic kidney disease
      • Hypertension
    • Clinical trials, DPP-4 inhibitors, and investigational drugs
    • Diabetes in different patient populations:
      • African Americans
      • Hispanics
    • Diabetic complications:
      • Hypoglycemia
      • Macrovascular
      • Nephropathy Ocular
Submission deadline: August 02
Fast-Track deadline: August 10
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
*NEW* Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
sitelicenses@postgradmed.com

Reprints:
reprints@postgradmed.com

Subscriptions:
subscriptions@postgradmed.com

Supplements:
supplements@postgradmed.com

Document Delivery Services 1946-2010:
documentdelivery@postgradmed.com

Editorial:
editor-in-chief@postgradmed.com editorial@postgradmed.com

Website:
support@postgradmed.com

Managing Director:
John Elduff
Phone: 610-889-3732
Fax: 1-866-297-3168
j.elduff@postgradmed.com

General Information
Phone: 610-889-3730
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 320
Berwyn, PA 19312
September 8, 2010
Print Features - Clinical Features
Most Viewed
  1. The Bioidentical Hormone Debate:
    Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?
  2. Prevention, Screening, and Management of Osteoporosis:
    An Overview of the Current Strategies
  3. Inflammatory Arthritis:
    An Overview for Primary Care Physicians
Weekly Poll
Advertisement image

Clinical Features

The Clinical Features section of Postgraduate Medicine features Original Research, Review Articles, and Case Reports.

Review Articles are comprehensive analyses and meta-analyses of specific topics that are relevant to our readers. Review articles published in Postgraduate Medicine are both solicited and unsolicited. The submitted article should describe current developments in the field of clinical medicine. All review articles should present content that is accessible to readers who are not intimately familiar with the subject being reviewed. As such, all review articles should increase readers' interest and describe important developments. We encourage authors to contact the editorial department to discuss any unsolicited article topics in order to avoid replication of previously published or already submitted articles. A signed author disclosure form is required before any submission can be published.

Original Research articles are formal investigative studies that focus on timely clinical issues. These reports typically include randomized trials, intervention studies, cohort studies, case-control studies, epidemiologic assessments, other observational studies, surveys with high response rates, cost-effectiveness analyses and decision analyses, and studies of screening and diagnostic tests. Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria and/or participation or response rates, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a comment section placing the results in context with the published literature and addressing study limitations; and the conclusions. Data included in research reports should be as current as possible. A signed author disclosure form is required before any submission can be published.

Case Reports should include the etiology, diagnosis, and management of a single case. Case reports should help primary care physicians improve patient care. They should include information on the background of the patient, how the initial diagnosis was reached, discussion of the differential diagnosis, and discussion about treatment and management. Case reports can focus on unique cases, unexpected associations, unusual side effects or adverse medication interaction, unusual disease presentation, management of new diseases, unexpected events during the treatment course, pathogenesis of a disease, or any other substantial findings of educational value. Data regarding suspected adverse drug reactions should provide a description of the event, details regarding the implicated medication (purpose, when initiated), previous adverse drug reactions with similar drugs, effects of dechallenge or rechallenge, and treatment for the reaction. The report should be factual, concise, logically organized, and clearly presented.

We encourage authors to submit relevant figures. Be sure to include any IRB protocol numbers if applicable. A signed author disclosure form is required before any submission can be published. As established in the AMA Manual of Style: A Guide for Authors and Editors (10th edition), we also require a signed informed consent statement specifying that the patient appearing in any identifiable images is aware that they will be featured in the submitted case report.